Analysis of haematological risk factors for thromboembolic events in anaemic cancer patients treated with epoetin beta

被引：0
|
作者：
Aapro, M.
Boogaerts, M.
Coiffier, B.
Hayward, C.
Burger, H.
机构：
[1] Clin Genolier, Inst Multidisciplinaire Oncol, Genolier, France
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] Ctr Hosp Lyon Sud, Lyon, France
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [31] Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials
    Ma, Zhuo
    Sun, Ximu
    Zhang, Yi
    Li, Hao
    Sun, Dan
    An, Zhuoling
    Zhang, Yuhui
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1757 - 1766
  • [32] Meta-analysis of the effects of epoetin alfa treatment on quality of life in anaemic cancer patients
    不详
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 : S16 - S18
  • [33] RISK FACTORS FOR THROMBOEMBOLIC EVENTS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
    Notarnicola, A.
    Nasman, L.
    Tang, Q.
    Tjarlund, A.
    Elvin, K.
    Berg, L.
    Norkko, J.
    Lundberg, I. E.
    Antovic, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1105 - 1106
  • [34] Risk Factors of Venous Thromboembolic Disease in Cancer Patients Treated with Immune Checkpoint Inhibitor
    le Seve, Julien Denis
    Guedon, Alexis F.
    Bordenave, Stephanie
    Agard, Christian
    Connault, Jerome
    Pistorius, Marc-Antoine
    Quereux, Gaelle
    Espitia, Olivier
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (11) : 1049 - 1056
  • [35] Risk factors associated with venous thromboembolic events in patients with malignancy
    Lin, Jules
    Wakefield, Thomas W.
    Henke, Peter K.
    BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (04) : 265 - 270
  • [36] Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan
    Miyamoto, Susumu
    Ikeda, Takanori
    Ogawa, Satoshi
    Kitazono, Takanari
    Nakagawara, Jyoji
    Minematsu, Kazuo
    Murakawa, Yuji
    Iwashiro, Sanghun
    Takeichi, Makiko
    Kidani, Yoko
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Sato, Shoichiro
    Yamanaka, Satoshi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (04):
  • [37] Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients
    Youssry, Ilham
    Soliman, Nohair
    Ghamrawy, Mona
    Samy, Rania Mohamed
    Nasr, Amal
    Mohsen, Mohamed Abdel
    ElShahaat, Mohamed
    Fakhredin, Rayan Bou
    Taher, Ali
    ANNALS OF HEMATOLOGY, 2017, 96 (04) : 597 - 603
  • [38] Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients
    Ilham Youssry
    Nohair Soliman
    Mona Ghamrawy
    Rania Mohamed Samy
    Amal Nasr
    Mohamed Abdel Mohsen
    Mohamed ElShahaat
    Rayan Bou Fakhredin
    Ali Taher
    Annals of Hematology, 2017, 96 : 597 - 603
  • [39] Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
    Lonial, Sagar
    Richardson, Paul G.
    Miguel, Jesus San
    Sonneveld, Pieter
    Schuster, Michael W.
    Blade, Joan
    Cavenagh, Jamie
    Rajkumar, S. Vincent
    Jakubowiak, Andrzej J.
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    Harousseau, Jean-Luc
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (02) : 222 - 229
  • [40] ULISES:: efficacy of epoetin beta in anaemic patients with B-cell lymphoproliferative malignancies
    Giraldo, P.
    Ferrer, S.
    Lopez-Hernandez, A.
    Marquez, J. A.
    EJC SUPPLEMENTS, 2007, 5 (04): : 354 - 354
12345